Retour
Fourchette du Jour
75,33 €
75,64 €
Fourchette 52 Semaines
51,90 €
75,75 €
Volume
2 533 612
Moyenne 50J / 200J
75,16 €
/
70,71 €
Clôture Précédente
75,41 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 29,9 | 0,4 |
| P/B | 3,4 | 2,9 |
| ROE % | 11,1 | 3,8 |
| Net Margin % | 13,8 | 3,9 |
| Rev Growth 5Y % | -7,6 | 10,0 |
| D/E | 0,5 | 0,2 |
Objectif de Cours des Analystes
Hold
77,80 €
+2.9%
Low: 76,00 €
High: 79,00 €
P/E Prévisionnel
17,1
BPA Prévisionnel
4,43 €
Croissance BPA (est.)
+0,0%
CA Est.
4,2 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
5,75 €
5,58 € – 5,87 €
|
4,9 B | 1 |
| FY2028 |
5,17 €
4,46 € – 5,88 €
|
4,6 B | 5 |
| FY2027 |
4,83 €
4,52 € – 5,10 €
|
4,4 B | 7 |
Points Clés
Revenue declined -7,63% annually over 5 years
Earnings declined -28,35% over the past year
ROE of 11,12% — decent returns on equity
Generating 920,10M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 9,37%
Cash machine — converts 162,65% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
-7,63%
Revenue (1Y)1,74%
Earnings (1Y)-28,35%
FCF Growth (3Y)1,05%
Qualité
Return on Equity
11,12%
ROIC6,98%
Net Margin13,80%
Op. Margin17,42%
Sécurité
Debt / Equity
0,52
Current Ratio3,75
Interest Coverage16,73
Valorisation
P/E Ratio
29,85
P/B Ratio3,35
EV/EBITDA24,57
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1,74% | Revenue Growth (3Y) | 0,87% |
| Earnings Growth (1Y) | -28,35% | Earnings Growth (3Y) | 11,38% |
| Revenue Growth (5Y) | -7,63% | Earnings Growth (5Y) | -25,85% |
| Profitability | |||
| Revenue (TTM) | 4,10B | Net Income (TTM) | 565,70M |
| ROE | 11,12% | ROA | 6,28% |
| Gross Margin | 61,00% | Operating Margin | 17,42% |
| Net Margin | 13,80% | Free Cash Flow (TTM) | 920,10M |
| ROIC | 6,98% | FCF Growth (3Y) | 1,05% |
| Safety | |||
| Debt / Equity | 0,52 | Current Ratio | 3,75 |
| Interest Coverage | 16,73 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 29,85 | P/B Ratio | 3,35 |
| P/S Ratio | 4,12 | PEG Ratio | -1,06 |
| EV/EBITDA | 24,57 | Dividend Yield | 0,00% |
| Market Cap | 16,89B | Enterprise Value | 17,55B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,10B | 4,03B | 4,03B | 4,86B | 5,63B |
| Net Income | 565,70M | 789,50M | 456,00M | 1,30B | 1,87B |
| EPS (Diluted) | 2,49 | 3,32 | 1,83 | 5,13 | 7,21 |
| Gross Profit | 2,50B | 2,23B | 2,07B | 3,00B | 3,80B |
| Operating Income | 714,30M | 882,60M | 668,40M | 1,64B | 2,48B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 9,01B | 9,16B | 9,14B | 9,07B | 8,92B |
| Total Liabilities | 3,97B | 4,03B | 4,12B | 4,20B | 4,70B |
| Shareholders' Equity | 5,05B | 5,13B | 5,02B | 4,88B | 4,22B |
| Total Debt | 2,63B | 2,66B | 2,90B | 2,92B | 3,14B |
| Cash & Equivalents | 1,96B | 2,16B | 2,72B | 2,34B | 1,17B |
| Current Assets | 3,67B | 3,82B | 4,18B | 3,86B | 3,17B |
| Current Liabilities | 977,20M | 1,04B | 1,21B | 937,70M | 1,33B |